Intravenous Thrombolysis in German Stroke Units before and after Regulatory Approval of Recombinant Tissue Plasminogen Activator

Publisher： Karger

E-ISSN： 1421-9786|22|5-6|429-431

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.22, Iss.5-6, 2006-11, pp. : 429-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran

By  

Cerebrovascular Diseases, Vol. 30, Iss. 5, 2010-09 ,pp. : 533-534

Karger

Access to resources Recommend Favorite

Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 288-295

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis for Acute Ischaemic Stroke: Preliminary Experience with Recombinant Tissue Plasminogen Activator in the UK

By  

Cerebrovascular Diseases, Vol. 20, Iss. 6, 2005-11 ,pp. : 438-442

Karger

Access to resources Recommend Favorite

Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time

By  

Cerebrovascular Diseases Extra, Vol. 3, Iss. 1, 2013-03 ,pp. : 35-45

Karger

Access to resources Recommend Favorite

Validation of FLAIR Hyperintense Lesions as Imaging Biomarkers to Predict the Outcome of Acute Stroke after Intra-Arterial Thrombolysis following Intravenous Tissue Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 35, Iss. 5, 2013-05 ,pp. : 461-468

Karger

Access to resources Recommend Favorite